The Next Generation of Platelet Rich Plasma | Worlds Largest Regenerative Sports Medicine Conference

About this video

Dr. Khan presents findings from the Ortho Biologics Institute conference on advanced platelet-rich plasma (PRP) injections. He argues that osteoarthritis is fundamentally an inflammatory condition, not merely wear-and-tear, and that modern PRP works through cellular signaling rather than stem cell engraftment. Dr. Khan describes his cyto-rich second-generation PRP, which he claims targets specific inflammatory pathways and shows improved outcomes versus standard PRP in knee osteoarthritis patients, with minimal side effects.

Key takeaways

• Osteoarthritis is driven by inflammation and cytokine imbalances, not just mechanical wear
• Modern regenerative injectables work through paracrine secretion and cell signaling, not tissue regrowth
• Cyto-rich second-generation PRP targets inflammatory mediators like IL-1 and TNF-alpha more effectively than standard PRP
• A large-scale 5,000-patient randomized trial is underway to compare standard PRP with cyto-rich PRP for osteoarthritis

Episode details: published April 19, 2022 · 1.7K views · 8:25 long. Summary written by Self Growth Videos from the episode itself. The regenerative-medicine concepts described are Dr. Khan’s, presented for education — not medical advice. Consult a qualified professional before changing your own health practices. Disclosure: Dr. Khan founded Eterna Health, which sells regenerative treatments.

← Previous: Full Back Workout Routine | How to Workout Smarter w/Worlds Strongest Doctor | Doctor Adeel · Next: The Secret To Longevity: Why David Sinclair Is Wrong →

All Dr. Adeel Khan videos · Dr. Adeel Khan profile · Eterna Health (official site)